122 related articles for article (PubMed ID: 12095072)
1. Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251.
Vinklerová J; Nováková J; Sulcová A
J Psychopharmacol; 2002 Jun; 16(2):139-43. PubMed ID: 12095072
[TBL] [Abstract][Full Text] [Related]
2. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
3. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats.
Carson DS; Cornish JL; Guastella AJ; Hunt GE; McGregor IS
Neuropharmacology; 2010 Jan; 58(1):38-43. PubMed ID: 19560473
[TBL] [Abstract][Full Text] [Related]
4. The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding.
Boctor SY; Martinez JL; Koek W; France CP
Eur J Pharmacol; 2007 Sep; 571(1):39-43. PubMed ID: 17628534
[TBL] [Abstract][Full Text] [Related]
5. Impact of cannabinoid receptor ligands on behavioural sensitization to antiaggressive methamphetamine effects in the model of mouse agonistic behaviour.
Landa L; Slais K; Sulcova A
Neuro Endocrinol Lett; 2006 Dec; 27(6):703-10. PubMed ID: 17187025
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.
Rodríguez de Fonseca F; Roberts AJ; Bilbao A; Koob GF; Navarro M
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1109-14. PubMed ID: 11189201
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.
Garcia R; Cotter AR; Leslie K; Olive MF; Neisewander JL
Int J Neuropsychopharmacol; 2017 Aug; 20(8):644-653. PubMed ID: 28444326
[TBL] [Abstract][Full Text] [Related]
8. Effects of cannabinoid receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys.
Schindler CW; Panlilio LV; Gilman JP; Justinova Z; Vemuri VK; Makriyannis A; Goldberg SR
Eur J Pharmacol; 2010 May; 633(1-3):44-9. PubMed ID: 20153314
[TBL] [Abstract][Full Text] [Related]
9. A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.
Hiranita T; Yamamoto T; Nawata Y
Neuroscience; 2010 Jan; 165(2):300-12. PubMed ID: 19883738
[TBL] [Abstract][Full Text] [Related]
10. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.
Adamczyk P; Miszkiel J; McCreary AC; Filip M; Papp M; Przegaliński E
Brain Res; 2012 Mar; 1444():45-54. PubMed ID: 22325096
[TBL] [Abstract][Full Text] [Related]
11. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
[TBL] [Abstract][Full Text] [Related]
12. The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.
Orio L; Wee S; Newman AH; Pulvirenti L; Koob GF
Addict Biol; 2010 Jul; 15(3):312-23. PubMed ID: 20456290
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine-seeking behavior is due to inhibition of nicotinic cholinergic transmission by activation of cannabinoid CB1 receptors.
Hiranita T; Nawata Y; Sakimura K; Yamamoto T
Neuropharmacology; 2008 Dec; 55(8):1300-6. PubMed ID: 18782581
[TBL] [Abstract][Full Text] [Related]
14. Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats.
Kangiser MM; Dwoskin LP; Zheng G; Crooks PA; Stairs DJ
Behav Pharmacol; 2018 Feb; 29(1):87-97. PubMed ID: 28863003
[TBL] [Abstract][Full Text] [Related]
15. Concurrent access to sucrose pellets decreases methamphetamine-seeking behavior in Lewis rats.
Ping A; Kruzich PJ
Pharmacol Biochem Behav; 2008 Sep; 90(3):492-6. PubMed ID: 18495228
[TBL] [Abstract][Full Text] [Related]
16. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.
De La Garza R; Mahoney JJ; Culbertson C; Shoptaw S; Newton TF
Pharmacol Biochem Behav; 2008 Apr; 89(2):200-8. PubMed ID: 18207225
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
[TBL] [Abstract][Full Text] [Related]
18. Effects of cannabinoid CB₁ receptor antagonist rimonabant on acquisition and reinstatement of psychostimulant reward memory in mice.
Yu LL; Zhou SJ; Wang XY; Liu JF; Xue YX; Jiang W; Lu L
Behav Brain Res; 2011 Feb; 217(1):111-6. PubMed ID: 20937331
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens.
Morra JT; Glick SD; Cheer JF
Neuropharmacology; 2012 Sep; 63(4):565-74. PubMed ID: 22609048
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeys.
Beardsley PM; Dance ME; Balster RL; Munzar P
Eur J Pharmacol; 2002 Jan; 435(2-3):209-16. PubMed ID: 11821028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
